
Is there a market rotation in favour of IT, pharma and auto? Dhananjay Sinha answers
Remove Ads
CEO & Co-Head– Institutional Equities,, says the IT sector is showing signs of recovery as US-China relations improve, easing investor concerns about order book uncertainty. Potential US tax cuts could further boost the sector. Significant corrections in IT stocks have created attractive valuations, leading to a possible rotation of investments into IT. Pharma and auto sectors may also benefit from this rotation.If you look at the market profile, there has been a good rebound, I would say, after the initial correction. If you look at the market capitalisation of NSE, it had actually shrunk by almost like Rs 90 lakh crore to the lows in February or end of February and from there on, the market cap erosion has actually narrowed quite substantially because of the recovery that has happened. We have recovered almost like Rs 70 lakh crore out of that.So, the balance is only Rs 20 lakh crore from the peak level that we saw in September last year. So, I would say what has happened is that sectors have taken turns to rebound. We had RBI also infusing liquidity substantially, so that has also played out. What is happening now is the IT sector which is actually gradually coming back and the fact that there was an overhang on the sector with the recession risk being priced into the US economy and it was a spillover effect of the US-China conflict, the engagement that is happening between US and China in thawing the lock jam is something that can be seen as positive for the IT sector because a lot of investors were concerned about the order book uncertainty that it had created.I would say the overhang is actually receding. There is also a possibility that the market might start pricing in tax cuts in the US as well. These are the two things that are moving in favour of the IT sector. IT stocks have seen significant correction and there is a certain amount of valuation that people might be looking at. All put together, there does seem to be this whole rotation across sectors moving in favour of IT now. So, IT is one sector. There are other sectors like pharma where there is a possibility of rotation in favour of them. Auto is another one, maybe.This news will have an effect on the alco-beverage companies. What the Maharashtra government has announced may create a certain amount of suspicion that other states might actually also announce. This could be because state governments are also struggling on the revenue side. There is a likelihood that people might expect or extrapolate this kind of a scenario in other states as well.I would say people will need to wait to see whether they get more clarity on this and whether this can create a trend. While we are positive fundamentally on space, we do have Allied Blenders in our list, but this is a regulatory risk that will need to settle down before we take a decisive view.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Time of India
16 minutes ago
- Time of India
Income Tax refunds jump 474% since 2013-14, issuance time improves in past 11 years
Synopsis India's Income Tax refunds have surged by 474% over the past 11 years, reaching Rs 4.77 lakh crore in 2024-25, outpacing the 274% growth in gross tax collections. The processing time for refunds has significantly decreased from 93 days in 2013 to just 17 days in 2024. This improvement is attributed to enhanced tax administration and digital infrastructure.


Time of India
19 minutes ago
- Time of India
Tech Park: Karnataka CM Siddaramaiah's meeting on Tuesday to decide on farmers offer to sell their land for Rs 3.5 cr per acre
Protesting farmers from Devanahalli have offered to give up 449 acres near the international airport for the proposed high-tech park if the government fixes a rate of Rs 3.5 crore per acre . The state government will take a decision on the demand at July 15 meeting to be chaired by Chief Minister Siddaramaiah. Industries Minister MB Patil , speaking to the media on Sunday, said he hoped a solution would emerge on Tuesday. The farmers are demanding higher compensation, suitable jobs for locals who are giving up their lands and declaring the surrounding areas as a yellow zone. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Villas For Sale in Dubai Might Surprise You Villas In Dubai | Search Ads Get Rates Patil said the government was keen to balance the interests of farmers with the need for industrialization. There are also demands from local protestors to preserve the agricultural lands, which has led to a thinking in the government to declare the region as a green zone. The government, the minister added, was aware not all protesters were genuine farmers and some of them have already entered into agreements with big builders agreeing to sell their lands for real estate. Live Events Farmers of Channarayapatna hobli in Bengaluru rural district have been on a protest seeking to stall the acquisition. The previous BJP regime had, on August 27, 2021, issued a preliminary notification proposing acquisition of 1,772.2 acres of land from 13 villages in Channarayapatna hobli. Patil, the industries minister, had said last month that the process of acquiring the remaining 1,232 acres of land will go on as planned before.


Economic Times
19 minutes ago
- Economic Times
Cipla eyes entry into India's weight management market amid rising demand and global competition
Synopsis Cipla is set to enter India's weight management market, addressing the increasing demand for obesity solutions, while also strengthening its central nervous system portfolio through strategic in-licensing deals and acquisitions, particularly in ADHD and Parkinson's disease. The company is also focusing on innovation-led solutions to combat antimicrobial resistance and aims to be a global, patient-centric healthcare leader. Agencies Representative image Drug major Cipla is preparing to foray into the weight management segment in India, its MD and global CEO Umang Vohra has Mumbai-based firm is also strengthening its presence in the central nervous system (CNS) therapeutic area, he stated in his address to shareholders in the company's Annual Report for 2024-25."Our efforts are rooted in understanding patient needs, reducing stigma, and delivering differentiated therapies for niche is emerging as a priority area for Cipla. With a clear strategic intent, we are preparing to enter the weight management segment in India, aiming to address the rising demand for effective obesity solutions," Vohra domestic drug firms are developing drugs for weight loss to capitalise on the growing market for obesity and diabetes drugmaker Eli Lilly & Co has already launched its anti-obesity drug Mounjaro in the country. Danish firm Novo Nordisk has also launched its anti-obesity drug Wegovy, indicated for both long-term chronic weight management and reduction in risk of major adverse cardiovascular the CNS segment, Cipla has successfully in-licensed Sanofi's India CNS product range, including Frisium, a leading brand in the anti-epileptic category, Vohra informed shareholders."Building on this momentum, we aim to pursue similar in-licensing deals or acquisitions in niche indications of attention deficit hyperactivity disorder (ADHD) and Parkinson's disease," he company is equally committed to addressing the global crisis of antimicrobial resistance (AMR), he added."Our AMR portfolio is evolving from volume-based to innovation-led, with four novel products in development," Vohra noted that the company's ambition is to be a global, innovation-led, patient-centric healthcare company that creates long-term value through science, empathy, and sustainability."We will continue to invest in big brands, strategic alliances, digital infrastructure, and next-generation therapies, while remaining rooted in our founding values of care and compassion," Vohra stated. Cipla's consolidated revenue stood at Rs 27,548 crore in FY25. Its consolidated net profit rose to Rs 5,272 crore during the period.